China SXT Pharmaceuticals (SXTC) Intangibles (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Intangibles of $6328.0 for Q1 2026, down 46.41% year-over-year from $11808.0 in Q1 2025, and down 25.83% quarter-over-quarter from $8532.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Intangibles (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Intangibles history runs 9 years deep, the most recent figure standing at $6328.0 for Q1 2026.
- In Q1 2026, Intangibles fell 46.41% year-over-year to $6328.0; the TTM figure through Mar 2026 stood at $6328.0 (down 46.41% YoY), while the FY2026 annual figure was $6328.0, down 46.41% from the prior year.
- Intangibles for Q1 2026 stood at $6328.0, down from $8532.0 in the prior quarter.
- The five-year high for Intangibles was $85728.0 in Q1 2022, with the low at $6328.0 in Q1 2026.
- The 5-year median for Intangibles is $19101.0 (2024), against an average of $25389.0.
- The sharpest annual moves came in 2022 and 2023: Intangibles advanced 3.35% in 2022, then tumbled 67.49% in 2023.
- China SXT Pharmaceuticals' Intangibles stood at $30724.0 in 2022, then fell by 26.72% to $22514.0 in 2023, then fell by 29.39% to $15898.0 in 2024, then slumped by 46.33% to $8532.0 in 2025, then slipped by 25.83% to $6328.0 in 2026.
- Business Quant data shows SXTC's Intangibles at $6328.0 in Q1 2026, $8532.0 in Q3 2025, and $11808.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 1.12 Bn |
| 10 | China SXT Pharmaceuticals | 31,435.20 | -28.14 Mn | - | 6,328.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,328.00 |
| Sep 30, 2025 | 8,532.00 |
| Mar 31, 2025 | 11,808.00 |
| Sep 30, 2024 | 15,898.00 |
| Mar 31, 2024 | 19,101.00 |
| Sep 30, 2023 | 22,514.00 |
| Mar 31, 2023 | 27,868.00 |
| Sep 30, 2022 | 30,724.00 |
| Mar 31, 2022 | 85,728.00 |
| Sep 30, 2021 | 42,353.00 |
| Mar 31, 2021 | 82,948.00 |
| Sep 30, 2020 | 48,198.00 |
| Mar 31, 2020 | 76,750.00 |
| Sep 30, 2019 | 53,386.00 |
| Mar 31, 2019 | 80,979.00 |
| Sep 30, 2018 | 52,077.00 |
| Mar 31, 2018 | 60,673.00 |